SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000850693-12-000011
Filing Date
2012-11-06
Accepted
2012-11-06 16:34:41
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q agn10-q2012q3.htm 10-Q 1857534
2 EXHIBIT 10.1 agnex10120120930.htm EX-10.1 6122
3 EXHIBIT 31.1 agnex31120120930.htm EX-31.1 12296
4 EXHIBIT 31.2 agnex31220120930.htm EX-31.2 12632
5 EXHIBIT 32 agnex3220120930.htm EX-32 12991
  Complete submission text file 0000850693-12-000011.txt   9865185

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT agn-20120930.xml EX-101.INS 1699054
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agn-20120930.xsd EX-101.SCH 54315
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agn-20120930_cal.xml EX-101.CAL 86920
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agn-20120930_def.xml EX-101.DEF 187692
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agn-20120930_lab.xml EX-101.LAB 715136
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agn-20120930_pre.xml EX-101.PRE 358918
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Filer) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10269 | Film No.: 121183659
SIC: 2834 Pharmaceutical Preparations